2020 年第 11 期 第 15 卷

前列腺动脉栓塞术治疗前列腺增生的临床效果

Clinical effect of prostatic artery embolization on prostatic hyperplasia

作者：刘晶磊1李亮1曹莉明1刘建裕1石电威2梁志会1

英文作者：Liu Jinglei1 Li Liang1 Cao Liming1 Liu Jianyu1 Shi Dianwei2 Liang Zhihui1

单位：1中国人民解放军联勤保障部队第九八〇医院血管外科，石家庄050082；2河北省衡水市安平县人民医院胸外肿瘤外血管外科053600

英文单位：1Department of Vascular Surgery the 980th Hospital of Joint Logistics Support Force of the Chinese People′s Liberation Army Shijiazhuang 050082 China; 2Department of Cardiothoracic Tumor Vascular Surgery Anping People′s Hospital Hebei Province Hengshui 053600 China

关键词：前列腺增生；前列腺动脉栓塞术；前列腺症状评分；经尿道前列腺等离子电切术；最大尿流率 

英文关键词：Prostatichyperplasia;Prostaticarteryembolization;Prostatesymptomscore;Transurethralplasmaresectionofprostate;Maximumurineflowrate

• 摘要：

• 目的 观察前列腺动脉栓塞术治疗前列腺增生的临床效果。方法 选取2015年1月至2018年12月中国人民解放军联勤保障部队第九八〇医院收治的200例前列腺增生患者为研究对象。按照随机数字表法分为观察组和对照组，各100例。观察组患者应用前列腺动脉栓塞术治疗，对照组患者应用经尿道前列腺等离子电切术治疗。观察对比2组患者的治疗效果、术后各指标以及并发症发生率。结果 观察组总有效率高于对照组［97.0%（97/100）比88.0%（88/100）］，差异有统计学意义（P<0.05）。观察组患者术后国际前列腺症状评分、最大尿流率、前列腺体积低于/小于对照组，生活质量评分、残余尿量高于/大于对照组，差异均有统计学意义（均P＜0.05）。观察组患者术后及随访36个月的并发症发生率低于对照组［7.0%（7/100）比16.0%（16/100）、3.0%（3/100）比14.0%（14/100）］，差异均有统计学意义（均P＜0.05）。结论 应用前列腺动脉栓塞术治疗前列腺增生效果显著，能改善临床各项指标，安全性好。

• Objective To observe the clinical effect of prostatic artery embolization on prostatic hyperplasia. Methods Totally 200 patients with prostate hyperplasia admitted to the 980th Hospital of Joint Logistics Support Force of the Chinese People′s Liberation Army from January 2015 to December 2018 were selected. Patients were divided into observation group（100 cases） and control group（100 cases） according to the random number table. Patients in observation group were treated with prostatic artery embolization, while patients in control group were treated with transurethral plasma resection of prostate. The therapeutic effect, postoperative indicators and incidence of complications in the two groups were observed and compared. Results The total effective rate of the observation group was higher than that of the control group［97.0%（97/100） vs 88.0%（88/100）, P<0.05］. Postoperative international prostate symptom score, maximum urine flow rate and prostate volume in observation group were lower/smaller than those in control group; quality of life score and residual urine were higher/larger than those of the control group(all P<0.05). The incidence of postoperative and 36 months follow-up complications in observation group were lower than those in control group［7.0%（7/100） vs 16.0%（16/100）, 3.0%（3/100） vs 14.0%（14/100）］(both P<0.05). ConclusionProstatic artery embolization in the treatment of prostatic hyperplasia can improve the clinical indicators.